Animal models of IgA nephropathy: Formulating therapeutic strategies
- 1 February 1997
- journal article
- Published by Wiley in Nephrology
- Vol. 3 (1) , 45-50
- https://doi.org/10.1111/j.1440-1797.1997.tb00188.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathyClinical and Experimental Immunology, 1995
- Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6Kidney International, 1994
- Pathogenesis of IgA nephropathy:In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretionThe Journal of Pathology, 1994
- Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindredClinical and Experimental Immunology, 1994
- Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathyKidney International, 1994
- Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritisKidney International, 1993
- Growth factors in glomerulonephritisKidney International, 1993
- Extrarenal cytokines modulate the glomerular response to IgA immune complexesKidney International, 1992
- Glomerular hemodynamics and eicosanoid synthesis in a rat model of IgA nephropathyKidney International, 1992
- Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathyKidney International, 1991